T9G — Vidac Pharma Holding Cashflow Statement
0.000.00%
Last trade - 00:00- €18.70m
- €18.67m
Annual cashflow statement for Vidac Pharma Holding, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 5 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -0.407 | -0.643 |
| Non-Cash Items | 0 | 0.207 |
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 0.016 | -0.075 |
| Change in Accounts Receivable | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -0.391 | -0.511 |
| Other Investing Cash Flow Items | 0 | 0.008 |
| Sale of Fixed Assets | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 0 | 0.008 |
| Financing Cash Flow Items | 0.03 | 0 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.282 | 0.444 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -0.123 | -0.089 |